CollPlant Biotechnologies annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies's operating margin was −484.31% for fiscal 2025.
View full CollPlant Biotechnologies company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −484.31% | +2865.40 pp |
| 2024 | 2024-12-31 | −3,349.71% | −3281.16 pp |
| 2023 | 2023-12-31 | −68.55% | +5649.51 pp |
| 2022 | 2022-12-31 | −5,718.06% | −5718.48 pp |
| 2021 | 2021-12-31 | 0.42% | +91.65 pp |
| 2020 | 2020-12-31 | −91.23% | +237.97 pp |
| 2019 | 2019-12-31 | −329.21% | −244.54 pp |
| 2018 | 2018-12-31 | −84.66% | +1201.95 pp |
| 2017 | 2017-12-31 | −1,286.61% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | −1,769.48% | −1537.04 pp |
| Q2 2023 | 2023-06-30 | 55.74% | +346.34 pp |
| Q2 2022 | 2022-06-30 | −6,340.91% | −5577.72 pp |
| Q2 2021 | 2021-06-30 | −443.27% | — |
| Q2 2020 | 2020-06-30 | −232.44% | — |
| Q2 2019 | 2019-06-30 | −290.59% | — |
| Q2 2018 | 2018-06-30 | −763.19% | — |
Over the last five reported fiscal years, CollPlant Biotechnologies's operating margin decreased from −91.23% to −484.31%, a change of −393.08 percentage points. The latest reported quarter, Q2 2024, shows −1,769.48%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies filings at SEC.gov ↗